The SV40 replicon model for analysis of anticancer drugs:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
San Diego, Calif. [u.a.]
Acad. Press [u.a.]
1996
|
| Schriftenreihe: | Biotechnology intelligence unit
|
| Schlagworte: | |
| Beschreibung: | 193 S. Ill., graph. Darst. |
| ISBN: | 0126536309 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV011230004 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 970304s1996 ad|| |||| 00||| eng d | ||
| 020 | |a 0126536309 |9 0-12-653630-9 | ||
| 035 | |a (OCoLC)34121051 | ||
| 035 | |a (DE-599)BVBBV011230004 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 050 | 0 | |a QR406.2.S56 | |
| 082 | 0 | |a 616.99/4061 |2 20 | |
| 084 | |a VS 9100 |0 (DE-625)147725:253 |2 rvk | ||
| 084 | |a XI 7000 |0 (DE-625)153024:12905 |2 rvk | ||
| 245 | 1 | 0 | |a The SV40 replicon model for analysis of anticancer drugs |c Robert M. Snapka |
| 264 | 1 | |a San Diego, Calif. [u.a.] |b Acad. Press [u.a.] |c 1996 | |
| 300 | |a 193 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a Biotechnology intelligence unit | |
| 650 | 4 | |a Antineoplastic agents |x Research |x Methodology | |
| 650 | 4 | |a DNA Replication |x drug effects | |
| 650 | 4 | |a DNA-drug interactions | |
| 650 | 4 | |a Models, Genetic | |
| 650 | 4 | |a SV40 (Virus) | |
| 650 | 4 | |a Simian virus 40 |x drug effects | |
| 650 | 4 | |a Simian virus 40 |x genetics | |
| 650 | 4 | |a Viral genetics | |
| 650 | 0 | 7 | |a Arzneimittelwechselwirkung |0 (DE-588)4003147-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Cytostatikum |0 (DE-588)4068347-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a DNS |0 (DE-588)4070512-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Simian Sarkomvirus |0 (DE-588)4192408-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |2 gnd |9 rswk-swf |
| 655 | 7 | |a Repliken |2 gnd |9 rswk-swf | |
| 689 | 0 | 0 | |a Simian Sarkomvirus |0 (DE-588)4192408-3 |D s |
| 689 | 0 | 1 | |a DNS |0 (DE-588)4070512-2 |D s |
| 689 | 0 | 2 | |a Cytostatikum |0 (DE-588)4068347-3 |D s |
| 689 | 0 | 3 | |a Arzneimittelwechselwirkung |0 (DE-588)4003147-0 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Simian Sarkomvirus |0 (DE-588)4192408-3 |D s |
| 689 | 1 | 1 | |a Repliken |A f |
| 689 | 1 | 2 | |a Cytostatikum |0 (DE-588)4068347-3 |D s |
| 689 | 1 | 3 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |D s |
| 689 | 1 | |5 DE-604 | |
| 700 | 1 | |a Snapka, Robert M. |e Sonstige |4 oth | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-007535763 | ||
Datensatz im Suchindex
| _version_ | 1804125729770700800 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV011230004 |
| callnumber-first | Q - Science |
| callnumber-label | QR406 |
| callnumber-raw | QR406.2.S56 |
| callnumber-search | QR406.2.S56 |
| callnumber-sort | QR 3406.2 S56 |
| callnumber-subject | QR - Microbiology |
| classification_rvk | VS 9100 XI 7000 |
| ctrlnum | (OCoLC)34121051 (DE-599)BVBBV011230004 |
| dewey-full | 616.99/4061 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.99/4061 |
| dewey-search | 616.99/4061 |
| dewey-sort | 3616.99 44061 |
| dewey-tens | 610 - Medicine and health |
| discipline | Chemie / Pharmazie Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02125nam a2200601 c 4500</leader><controlfield tag="001">BV011230004</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">970304s1996 ad|| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0126536309</subfield><subfield code="9">0-12-653630-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)34121051</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV011230004</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">QR406.2.S56</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.99/4061</subfield><subfield code="2">20</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VS 9100</subfield><subfield code="0">(DE-625)147725:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 7000</subfield><subfield code="0">(DE-625)153024:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">The SV40 replicon model for analysis of anticancer drugs</subfield><subfield code="c">Robert M. Snapka</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">San Diego, Calif. [u.a.]</subfield><subfield code="b">Acad. Press [u.a.]</subfield><subfield code="c">1996</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">193 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Biotechnology intelligence unit</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antineoplastic agents</subfield><subfield code="x">Research</subfield><subfield code="x">Methodology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">DNA Replication</subfield><subfield code="x">drug effects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">DNA-drug interactions</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Models, Genetic</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">SV40 (Virus)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Simian virus 40</subfield><subfield code="x">drug effects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Simian virus 40</subfield><subfield code="x">genetics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Viral genetics</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelwechselwirkung</subfield><subfield code="0">(DE-588)4003147-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">DNS</subfield><subfield code="0">(DE-588)4070512-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Simian Sarkomvirus</subfield><subfield code="0">(DE-588)4192408-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="a">Repliken</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Simian Sarkomvirus</subfield><subfield code="0">(DE-588)4192408-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">DNS</subfield><subfield code="0">(DE-588)4070512-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Arzneimittelwechselwirkung</subfield><subfield code="0">(DE-588)4003147-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Simian Sarkomvirus</subfield><subfield code="0">(DE-588)4192408-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Repliken</subfield><subfield code="A">f</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="3"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Snapka, Robert M.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-007535763</subfield></datafield></record></collection> |
| genre | Repliken gnd |
| genre_facet | Repliken |
| id | DE-604.BV011230004 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T18:06:12Z |
| institution | BVB |
| isbn | 0126536309 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-007535763 |
| oclc_num | 34121051 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 193 S. Ill., graph. Darst. |
| publishDate | 1996 |
| publishDateSearch | 1996 |
| publishDateSort | 1996 |
| publisher | Acad. Press [u.a.] |
| record_format | marc |
| series2 | Biotechnology intelligence unit |
| spelling | The SV40 replicon model for analysis of anticancer drugs Robert M. Snapka San Diego, Calif. [u.a.] Acad. Press [u.a.] 1996 193 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Biotechnology intelligence unit Antineoplastic agents Research Methodology DNA Replication drug effects DNA-drug interactions Models, Genetic SV40 (Virus) Simian virus 40 drug effects Simian virus 40 genetics Viral genetics Arzneimittelwechselwirkung (DE-588)4003147-0 gnd rswk-swf Cytostatikum (DE-588)4068347-3 gnd rswk-swf DNS (DE-588)4070512-2 gnd rswk-swf Simian Sarkomvirus (DE-588)4192408-3 gnd rswk-swf Arzneimittelentwicklung (DE-588)4143176-5 gnd rswk-swf Repliken gnd rswk-swf Simian Sarkomvirus (DE-588)4192408-3 s DNS (DE-588)4070512-2 s Cytostatikum (DE-588)4068347-3 s Arzneimittelwechselwirkung (DE-588)4003147-0 s DE-604 Repliken f Arzneimittelentwicklung (DE-588)4143176-5 s Snapka, Robert M. Sonstige oth |
| spellingShingle | The SV40 replicon model for analysis of anticancer drugs Antineoplastic agents Research Methodology DNA Replication drug effects DNA-drug interactions Models, Genetic SV40 (Virus) Simian virus 40 drug effects Simian virus 40 genetics Viral genetics Arzneimittelwechselwirkung (DE-588)4003147-0 gnd Cytostatikum (DE-588)4068347-3 gnd DNS (DE-588)4070512-2 gnd Simian Sarkomvirus (DE-588)4192408-3 gnd Arzneimittelentwicklung (DE-588)4143176-5 gnd |
| subject_GND | (DE-588)4003147-0 (DE-588)4068347-3 (DE-588)4070512-2 (DE-588)4192408-3 (DE-588)4143176-5 |
| title | The SV40 replicon model for analysis of anticancer drugs |
| title_auth | The SV40 replicon model for analysis of anticancer drugs |
| title_exact_search | The SV40 replicon model for analysis of anticancer drugs |
| title_full | The SV40 replicon model for analysis of anticancer drugs Robert M. Snapka |
| title_fullStr | The SV40 replicon model for analysis of anticancer drugs Robert M. Snapka |
| title_full_unstemmed | The SV40 replicon model for analysis of anticancer drugs Robert M. Snapka |
| title_short | The SV40 replicon model for analysis of anticancer drugs |
| title_sort | the sv40 replicon model for analysis of anticancer drugs |
| topic | Antineoplastic agents Research Methodology DNA Replication drug effects DNA-drug interactions Models, Genetic SV40 (Virus) Simian virus 40 drug effects Simian virus 40 genetics Viral genetics Arzneimittelwechselwirkung (DE-588)4003147-0 gnd Cytostatikum (DE-588)4068347-3 gnd DNS (DE-588)4070512-2 gnd Simian Sarkomvirus (DE-588)4192408-3 gnd Arzneimittelentwicklung (DE-588)4143176-5 gnd |
| topic_facet | Antineoplastic agents Research Methodology DNA Replication drug effects DNA-drug interactions Models, Genetic SV40 (Virus) Simian virus 40 drug effects Simian virus 40 genetics Viral genetics Arzneimittelwechselwirkung Cytostatikum DNS Simian Sarkomvirus Arzneimittelentwicklung Repliken |
| work_keys_str_mv | AT snapkarobertm thesv40repliconmodelforanalysisofanticancerdrugs |